News

WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated a voluntary recall for a ...
Abbott’s continuous glucose monitoring (CGM) device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management. The integration is available for ...
Abbott has launched the new Libre app in the U.S., making it easier than ever for users of both the FreeStyle Libre 2 and FreeStyle Libre 3 systems to track glucose readings and insights.